In addition, pathological types also had a strong correlation with mutational profile (p < 0.001), and all twelve (100%) tumors were classified as papillary craniopharyngiomas in the BRAF mutation group while eighteen (81.8%) of twenty-two tumors were classified as adamantinomatous craniopharyngiomas in the CTNNB1 mutation group. This evidence concerns the gene CTNNB1 and craniopharyngioma.